The following observations are drawn from a recent talk I gave at the US-China Business Council, which was called “IP in the Trade War: Strategies for a New Normal.” A video recap […]
The Good Faith Elephant in the IP Trade War
It is impossible to talk about structural issues in China’s IP regime and its impact upon foreigners without addressing the lack of a comprehensive approach to “bad faith” activities in all its […]
Public Comment Draft of Patent Law Revisions Released by NPC
The National People’s Congress has released a public comment draft of the long-awaited revised patent law on its website . Here is the draft itself, and here are the official explanations on the draft […]
Trade and Peace on Earth: Part 2
In the first part of this blog, I talked about unilateral steps that the United States and China have been taking during the ‘trade war’ to address concerns regarding forced tech transfer. […]
Trade and Peace on Earth: Part 1
O ye who read this truthful rime From Flanders, kneel and say: God speed the time when every day Shall be as Christmas Day. (Frederick Niven, “A Carol from Flanders”, regarding the […]
A Potpourri of AIPLA Legislative Comments — And Other Developments
The American Intellectual Property Law Association has once again made its comments on proposed changes to Chinese IP legislation (laws, regulations, rules, examination guidelines, judicial interpretations, etc. ) available to this blog. Attached […]
“Dying to Survive” and Pharmaceutical IP Reform in China
Last week while in Beijing, I finally had the opportunity to see “Dying to Survive” (Chinese title: “我不是药神”[translation: I am not the god of medicines]), the hit Chinese movie which concerns the […]
April 10 – 16, 2018 Updates
1.New Policies for Innovative Drugs in China. Premier Li Keqiang held an executive meeting of the State Council on April 12, 2018 to adopt a series of measures to encourage the importation […]
April 3 – 9, 2018 Updates
1.China pushes generics over brands with another round of new pharma policies. The General Office of the State Council on April 3rd, 2018 issued “The Opinion on Reforming and Improving Supply and Use […]
IP House’s Snapshot of Medical and Health Industry
IP House has recently published a Statistical Report on IP Cases in the Medical and Health Industry (December 2017) (Chinese language) covering 391 medical and health industry cases closed from January 1, […]
China IPR - Intellectual Property Developments in China 